Please provide your email address to receive an email when new articles are posted on . Dulaglutide, semaglutide and tirzepatide had similar GI safety profiles. An increased risk for GI adverse events ...

Gastrointestinal adverse events, in particular diarrhea, are still a significant problem regardless of whether the patient is on treatment or which combination they are taking. [1,10,11] There is a ...

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged. Now real-world evidence ...

Credit: Getty Images As more reports surface about gastroparesis developing in patients who receive treatment with semaglutide, what should clinicians keep in mind? Semaglutide-containing medications ...

Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...

NCI sponsored, ECOG-ACRIN Phase 3 Study of Leukine in Combination with Ipilimumab and Nivolumab in Front Line Treatment of Melanoma Heads to Last Stages of Enrollment LEXINGTON, Mass., April 18, 2024 ...